NAP1L3
Nucleosome assembly protein 1-like 3
Also known as: MB20, MGC26312, NP1L3_HUMAN, NPL3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99457
- Gene
- NAP1L3
- Ensembl
- ENSG00000186310
- Chromosome
- X
- Canonical length
- 506 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Vesicles
OverviewNCBI Gene
This gene is intronless and encodes a member of the nucleosome assembly protein (NAP) family. This gene is linked closely to a region of genes responsible for several X-linked cognitive disability syndromes. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
506 residues, UniProt reviewed canonical sequence.
>Q99457|NAP1L3
1 MAEADFKMVS EPVAHGVAEE EMASSTSDSG EESDSSSSSS STSDSSSSSS TSGSSSGSGS
61 SSSSSGSTSS RSRLYRKKRV PEPSRRARRA PLGTNFVDRL PQAVRNRVQA LRNIQDECDK
121 VDTLFLKAIH DLERKYAELN KPLYDRRFQI INAEYEPTEE ECEWNSEDEE FSSDEEVQDN
181 TPSEMPPLEG EEEENPKENP EVKAEEKEVP KEIPEVKDEE KEVPKEIPEV KAEEKADSKD
241 CMEATPEVKE DPKEVPQVKA DDKEQPKATE AKARAAVRET HKRVPEERLQ DSVDLKRARK
301 GKPKREDPKG IPDYWLIVLK NVDKLGPMIQ KYDEPILKFL SDVSLKFSKP GQPVSYTFEF
361 HFLPNPYFRN EVLVKTYIIK AKPDHNDPFF SWGWEIEDCK GCKIDWRRGK DVTVTTTQSR
421 TTATGEIEIQ PRVVPNASFF NFFSPPEIPM IGKLEPREDA ILDEDFEIGQ ILHDNVILKS
481 IYYYTGEVNG TYYQFGKHYG NKKYRKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NAP1L3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 120 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 120 nTPM
- cerebral cortex: 112 nTPM
- hypothalamus: 108 nTPM
- amygdala: 60 nTPM
- basal ganglia: 60 nTPM
- hippocampal formation: 54 nTPM
Single-cell type
- other brain neurons: 84 nCPM
- brain inhibitory neurons: 64 nCPM
- brain excitatory neurons: 47 nCPM
- retinal amacrine cells: 41 nCPM
- retinal horizontal cells: 38 nCPM
- corticotrophs: 30 nCPM
Immune cell
- naive CD4 T-cell: 4.1 nTPM
- NK-cell: 3.1 nTPM
- naive CD8 T-cell: 2.9 nTPM
- memory CD4 T-cell: 2.6 nTPM
- gdT-cell: 1.9 nTPM
- memory CD8 T-cell: 0.9 nTPM
Brain region
- cerebral cortex: 146 nTPM
- basal ganglia: 128 nTPM
- midbrain: 128 nTPM
- hypothalamus: 126 nTPM
- pons: 109 nTPM
- thalamus: 93 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0.09
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NAP1L3 as an antibody target. Whether an autoantibody or antibody against NAP1L3 could matter depends on whether native NAP1L3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NAP1L3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NAP1L3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...